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Abstract
Background: Intracerebral transplantation of human induced pluripotent stem cells (iPSCs) can ameliorate
behavioral deficits in animal models of stroke. How the ischemic lesion affects the survival of the
transplanted cells, their proliferation, migration, differentiation, and function is only partly understood.
Methods: Here we have assessed the influence of the stroke-induced injury on grafts of human skin iPSCs-
derived long-term neuroepithelial-like stem cells using transplantation into the rostral migratory stream (RMS), adjacent
to the neurogenic subventricular zone, in adult rats as a model system.
Results: We show that the occurrence of an ischemic lesion, induced by middle cerebral artery occlusion, in the
striatum close to the transplant does not alter the survival, proliferation, or generation of neuroblasts or mature
neurons or astrocytes from the grafted progenitors. In contrast, the migration and axonal projection patterns
of the transplanted cells are markedly influenced. In the intact brain, the grafted cells send many fibers to the main
olfactory bulb through the RMS and a few of them migrate in the same direction, reaching the first one third of this
pathway. In the stroke-injured brain, on the other hand, the grafted cells only migrate toward the ischemic lesion and
virtually no axonal outgrowth is observed in the RMS.
Conclusions: Our findings indicate that signals released from the stroke-injured area regulate the migration of and
fiber outgrowth from grafted human skin-derived neural progenitors and overcome the influence on these cellular
properties exerted by the neurogenic area/RMS in the intact brain.
Keywords: Adult neurogenesis, Human skin-derived cells, Pluripotent, Rostral migratory stream, Stroke, Subventricular
zone, Transplantation
Background
Intracerebral transplantation of induced pluripotent
stem cells (iPSCs) or their derivatives, generated by
reprogramming human somatic cells, can reverse
behavioral deficits in experimental stroke models (for
references, see [1]). Improvements were detected early
after transplantation, indicating that they were not due
to neuronal replacement but to other mechanisms
such as modulation of inflammation, and promotion
of plastic responses and neovascularization. However,
we recently showed that human iPSC-derived long-
term neuroepithelial-like stem cells (lt-NESCs) trans-
planted into stroke-injured cortex can differentiate to
form functional cortical neurons, which receive affer-
ent inputs from appropriate brain areas and respond
to mechanical stimulation of nose and paw [2]. It
remains to be demonstrated, though, that this incorp-
oration into host neural circuitry contributes to the
long-term functional recovery after stroke.
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A fundamental question, also in a clinical-therapeutical
perspective, is how the stroke-induced injury affects the
survival, proliferation, migration, neuronal differentiation,
integration and function of the grafted human iPSC-
derived cells. Implantation of the cells in the rostral migra-
tory stream (RMS), close to one of the main neurogenic
areas in the brain, the subventricular zone (SVZ), seems
to be a useful model system to address these issues. In the
SVZ, neural stem/progenitor cells form new neurons that
travel, via the RMS, toward the main olfactory bulb
(MOB) [3], where they integrate as interneurons in the
granule and periglomerular cell layers. Several cues have
been identified which take part in this process [4–6] and
may regulate the behavior also of cells transplanted close
to the SVZ into the adult rodent brain. For example, dif-
ferentiated neurons from a human teratocarcinoma send
their axons through the RMS and in association with ipsi-
lateral and contralateral white matter pathways [7]. When
implanting human skin-derived iPSCs close to the SVZ in
adult intact brains, most of the grafted cells migrate via
the RMS. In contrast, oligodendrocytes implanted do not
migrate along the RMS but follow the white matter path-
ways along the corpus callosum and internal capsule [8].
Whether the occurrence of an ischemic lesion affects the
migration, axonal outgrowth or other properties of human
iPSCs implanted close to the SVZ is unknown.
Here we have explored the role of the ischemic injury
for the behavior of human iPSC-derived lt-NESCs after
transplantation into the RMS, adjacent to the neurogenic
SVZ, in intact and stroke-damaged rats. We demon-
strate that the stroke-induced lesion markedly alters the
patterns of axonal outgrowth and migration of the
grafted cells, whereas survival, proliferation, and gener-




Male (225–250 g) Sprague-Dawley (SD) rats (n = 16;
Charles River Laboratories Wilmington, MA, USA) were
used. They were housed in standard caging under a
12-hour light/dark cycle with ad libitum access to
food and water.
Cell culture
The human iPSC-derived lt-NESCs were produced from
human skin fibroblasts as previously described [9].
Briefly, human fibroblasts were subjected to retroviral
transduction with plasmids encoding for the viral glyco-
protein VSV-G and the reprogramming factors Oct4,
Sox2, KLF4, and c-MYC and split into plates with mouse
embryonic fibroblasts. Colonies were then picked and
expanded to establish human iPSC lines. Those lines
were induced to differentiate to neural phenotype as
previously described [10] through an embryoid body-
production step. Neural rosettes were generated and
carefully picked and grown in the presence of 10 ng/ml
fibroblast growth factor (FGF) 2, 10 ng/ml epidermal
growth factor (EGF; both from R&D Systems, Inc.,
Minneapolis, MN, USA), and 1 μl/ml B27 (Invitrogen,
Carlsbad, CA, USA). The human iPSC-derived lt-NES
cell line was routinely cultured and expanded on 0.1 mg/ml
poly-L-ornithine- and 10 μg/ml laminin- (both from
Sigma-Aldrich, St. Louis, MO, USA) coated plates in the
same media supplemented with FGF, EGF and B27.
The lt-NESCs were passaged at a ratio of 1:2 to 1:3 every
second to third day using trypsin (Sigma-Aldrich).
Middle cerebral artery occlusion
Stroke was induced using the intraluminal filament
model of middle cerebral artery occlusion (MCAO) as
previously described [11, 12]. Briefly, right common
carotid artery (CCA) and its proximal branches were
isolated. The CCA and external carotid artery (ECA)
were ligated, and internal carotid artery (ICA) was tem-
porarily occluded using a metal micro-vessel clip. A
nylon monofilament was advanced through the CCA
and ICA until resistance was felt (approximately 9 mm
distance) past the origin of the middle cerebral artery.
The nylon filament was carefully removed after 30 mi-
nutes occlusion, the ECA was ligated permanently, and
the surgical wound was closed. Special care was taken
for a week after surgery. A high-calorie gel diet (Diet-
Gel™ Boost, ClearH2O, Westbrook, ME, USA) was supple-
mented and Ringer’s solution was injected subcutaneously
daily in case of dehydration.
Transplantation
Intracerebral transplantation of human iPSC-derived lt-
NESCs, which previously had been transduced with
lentivirus carrying green fluorescent protein (GFP), was
performed stereotaxically. At the day of surgery, cells
were resuspended to a final concentration of 105 cells/μl.
A volume of 2 μl was injected at the following coordi-
nates (from bregma and brain surface): anterior/poster-
ior (AP): +1.8 mm; medial/lateral (M/L): +1.7 mm;
dorsal/ventral (D/V): -4 mm. Tooth bar was set at
-3.3 mm. Rats were given subcutaneous injections of
10 mg/kg Cyclosporine A every day during the first
month after transplantation and every other day during
the second month.
Immunohistochemistry
Rats were sacrificed and perfused transcardially with 4%
paraformaldehyde. Sagittal sections (30 μm) of fixed
brains obtained with a microtome were preincubated in
blocking solution (5% normal serum and 0.25% Triton
X-100 in 0.1 M potassium phosphate-buffered saline).
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Sections were incubated at +4 °C overnight with primary
antibodies diluted in blocking solution. The following
antibodies were used: chicken anti-green fluorescent
protein (GFP; 1:5000 EMD Millipore, Billerica, MA,
USA), mouse anti-NeuN (1:500 EMD Millipore), mouse
anti-human cytoplasm SC121 (1:200 StemCell Tech-
nologies, Vancouver, BC, Canada), mouse anti-human
nuclei SC101 (1:500 StemCell Technologies), rabbit anti-
Ki67 (1:400 Novacastra Laboratories, Newcastle, UK),
mouse anti-human glial fibrillary acidic protein (GFAP;
1:500 Stem Cell Technologies), rabbit anti-kidney-type
glutaminase (KGA; 1:200 Abcam, Cambridge, MA,
USA), goat anti-doublecortin (DCX; 1:400 Santa Cruz
Biotechnologies, Dallas, TX, USA), and rabbit anti-
GAD65/67 (1:400 Sigma-Aldrich). Primary antibodies
were detected with appropriate fluorescent or biotinyl-
ated secondary antibodies (1:200 The Jackson Laborator-
ies, Bar Harbor, ME USA). Hoechst 33342 (1:4000
Invitrogen) was used to label cell nuclei.
Quantifications
Numbers of cells immunoreactive for the different
markers were estimated stereologically using C.A.S.T.-
Grid software (Visiopharm, Hørsholm, Denmark).
Around 500 cells per animal were counted in a prede-
fined fraction of the graft area in an epifluorescence/
light microscope. Results for NeuN and Ki67 were
expressed as percentage of total number of SC101+ cells.
For human-specific GFAP and KGA, the fraction of
grafted area (GFP+) immunoreactive for each marker
was identified with defined representative ranges of
threshold for specific signal using image analysis with
CellSens Dimension 2010 software (Olympus, Tokyo,
Japan), which calculated the total area covered by pixels/
specific immunopositive signal. Colocalization of differ-
ent markers was in all cases validated in a confocal
microscope (Carl Zeiss Microscopy GmbH, Jena,
Germany).
To estimate fiber density, GFP+/SC121+ immuno-
staining was used. All fibers crossing the rostral turn of
RMS and fibers arriving to the MOB were counted and
compared between groups.
For analysis of migration, all nuclei of grafted cells were
located based on SC101 immunostaining. Distance from
each grafted cell to the injection site was calculated using
ImageJ software. Mean and maximum distances of migra-
tion were compared between groups.
Statistics
Comparisons were performed with Prism 6 software
(GraphPad Software, San Diego, CA, USA) using un-
paired t test. Data are presented as mean ± SEM, and
differences considered significant at P < 0.05.
Results
Stroke does not affect survival, proliferation, or
differentiation of human skin-derived neural progenitors
transplanted adjacent to subventricular zone
In this experiment, eight intact adult rats received trans-
plants of human iPSC-derived lt-NESCs into the RMS,
close to the SVZ (Fig. 1a). Another eight rats were sub-
jected to MCAO and after 48 hours were implanted in the
same way. Two months later, both groups of animals were
sacrificed and perfused, brains were sectioned in the sagit-
tal plane and analyzed by immunohistochemistry.
The transplanted cells were identified using the
human-specific nuclear marker SC101. We found that
the implantation site, as determined by SC101 staining
and localization of the injection track, was situated in
the RMS, 0.5 to 1 mm anterior to the lateral ventricle in
all animals, without difference between the groups.
Using NeuN staining, we then assessed the location of
the ischemic damage in the stroke-subjected animals.
Neuronal loss was confined to the lateral striatum. The
distance from the border of the ischemic injury to the
implantation site varied, depending of the extent of the
damage, between 1 and 3 mm with an average value of
1.82 mm. There was no significant difference in num-
bers of grafted cells between stroke-subjected and intact
rats at 2 months after transplantation (Fig. 1b and d-e).
Similarly, we did not find any difference between the
two animal groups in either the numbers of proliferating
Ki67+ cells within the grafts (Fig. 1c and f-g) or the per-
centage of grafted cells immunopositive for the neuro-
blast marker DCX (59 ± 2.6% and 54.5 ± 4.3% of grafted
cells in intact and stroke-injured rats, respectively;
Fig. 1h-i).
We have previously shown that human iPSC-derived
lt-NESCs differentiate to mature neurons and, in a small
percentage, to mature astrocytes after transplantation
into the stroke-injured brain [13, 14]. To determine
whether the ischemic lesion affects this differentiation
process, we evaluated the capacity of the grafted cells to
form mature neurons and astrocytes at 2 months after
transplantation into the RMS, close to the SVZ. We
found that more than 15% of the grafted cells expressed
the mature neuronal marker NeuN when transplanted
into the intact brain (16.7 ± 1.6%; Fig. 2a). This percent-
age did not differ from that found in animals subjected
to stroke (19.8 ± 1.2%; Fig. 2b-c). As expected, the pro-
portion of astrocytes immunopositive for human-specific
GFAP, generated from the human iPSC-derived lt-
NESCs transplanted into the intact brain, was very low
at 2 months after transplantation (0.18 ± 0.07% of grafted
area covered by GFAP; Fig. 2d and e). The ischemic
lesion did not alter this percentage (0.26 ± 0.12%; Fig. 2d
and f). Analysis of the phenotype of the neurons gener-
ated from the grafted cells showed that the majority of































































































Fig. 1 Stroke does not alter survival or proliferation of human skin-derived neural progenitors transplanted adjacent to SVZ. a Schematic
representation of transplantation approach and injection site in relation to different structures. b-c Survival (b) and proliferation (c) of
grafted cells in intact (n = 6) and stroke-subjected (MCAO; n = 7) rats at 2 months after transplantation. Data represent means ± SEM.
d-e Fluorescence photomicrographs showing location of grafted cells (GFP+, green) transplanted in the intact (d) and stroke-injured
(MCAO) rats (e) immunostained (in red) with human-specific marker SC101, in relation to RMS. f-g Fluorescence photomicrographs showing examples
of grafted cells (GFP+, green) transplanted in the intact (f) and stroke-injured (MCAO) rats (g) co-expressing Ki67 (in red). Hoechst nuclear counterstain
(in blue) is included in (f-g). h-i Fluorescence photomicrographs showing examples of grafted cells (GFP+, green) transplanted in the intact (h) and
stroke-injured (MCAO) rats (i) immunostained with SC101 (in red) and co-expressing DCX (in orange). Arrows depict examples of GFP+/SC101+/DCX+
cells. Ctx cortex, LV lateral ventricle, SVZ subventricular zone, Str striatum, RMS rostral migratory stream, MOB main olfactory bulb. Scale bars represent
300 μm in (d and e), 50 μm in (f and g) and 25 μm in (h and i)





























































































































Fig. 2 Stroke does not affect differentiation capacity of human skin-derived neural progenitors transplanted adjacent to SVZ. a-b Fluorescence
photomicrographs showing grafted cells (GFP+, green) co-expressing the mature neuron-specific marker NeuN (red) and Hoechst counterstain
(blue) 2 months after transplantation in intact (a) and stroke-subjected (MCAO, b) rats. Arrows depict grafted NeuN+ cells while arrowheads depict
host NeuN+ cells. c-d Percentage of NeuN+ cells (c) and GFAP+ area (d) in the grafts from intact (n = 6) and stroke-injured (n = 7) rats. Data repre-
sent means ± SEM. Fluorescence photomicrographs showing grafted cells (GFP+, green) co-expressing human-specific GFAP (in red) 2 months
after transplantation in intact (e) and stroke-injured (MCAO, f) rats. Arrows depict grafted GFAP+ cells. g Percentage KGA+ area (glutamatergic
neuron marker) in grafts from intact (n = 6) and stroke-subjected (n = 7) rats. Data represent means ± SEM. h -i Fluorescence photomicrographs
showing grafted cells (GFP+, green) co-expressing KGA (in red) 2 months after transplantation in intact (h) and stroke-subjected (MCAO, i) rats.
Scale bars represent 25 μm
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them were positive for the glutamatergic neuron-specific
marker KGA with no difference between the groups
(66.1 ± 3.8% and 60.2 ± 2.8% of grafted area covered for
intact and stroke-subjected animals, respectively; Fig. 2g-
i). Accordingly, only few grafted cells were immunoposi-
tive for the GABAergic neuron-specific marker GAD65/
67 (data not shown).
Stroke alters migration and axonal projection patterns of
human skin-derived neural progenitors transplanted adja-
cent to subventricular zone
The human iPSC-derived lt-NESCs implanted near the
SVZ in the intact brain showed a selective but limited
migration along the descending limb of the RMS (for
definition, see e.g., [15]). Thus, in these animals a small
portion of grafted cells followed the normal pathway for
migration of neuroblasts generated in the SVZ to the
MOB (Fig. 3a-b), but never reached beyond the rostral
turn of the RMS. In contrast, in the group of rats sub-
jected to stroke, the grafted cells showed a completely
different migration pattern (Fig. 3c-d). In this case, the
majority of transplanted cells left the RMS and migrated
in the opposite direction toward the damaged area of
the striatum. We also found that the mean distance
which the grafted cells had migrated from the implant-
ation site at 2 months after transplantation was longer in
stroke-affected animals as compared to intact ones
(795.4 ± 140.8 and 399.9 ± 44.96 μm, respectively). How-
ever, the maximum distance from the implantation site
reached by the grafted cells was similar in both groups
(Fig. 3e-f ).
Finally, we analyzed the fiber outgrowth from the
grafted cells at 2 months after transplantation. In both
groups of animals, the human iPSC-derived lt-NESCs
transplanted into the RMS sent fibers to different areas
of the brain, including some tangential projections to
the cortex and the striatum, and others following white
matter tracts like corpus callosum. When transplanted
into the intact brain, the grafted cells also sent massive
number of fibers through the RMS, reaching the granu-
lar and glomerular layers of the MOB (Fig. 4a-d). An
average of more than 300 fibers per animal reached the
rostral turn of the RMS, and more than 100 fibers
arrived to the MOB (Fig. 4e and g-h). In contrast, in the
stroke-injured animals, virtually no fibers reached the
granular layer of the MOB and only very few the rostral
turn of the RMS (Fig. 4f-g).
Discussion
The results of the present study indicate that the pres-
ence of an ischemic lesion does not influence the sur-
vival, proliferation or differentiation of grafted cells after
transplantation of human iPSC-derived lt-NESCs adja-
cent to a neurogenic area, i.e., the SVZ. In contrast, an
ischemic injury causes marked changes in the migration
and axonal projection patterns of the grafted cells. Thus,
we found that in the intact brain, the grafted cells mi-
grated a short distance from the implantation site along
the RMS but sent massive number of fibers in the RMS
reaching the MOB. In the stroke-damaged brain, on the
other hand, the grafted cells migrated toward the ische-
mic lesion and the number of fibers sent through the
RMS was dramatically reduced.
Transplantation of neural precursors in non-
neurogenic areas of intact brains can lead to death of
grafted cells within 1 week [8, 16]. Therefore, in order to
allow graft survival also in the intact brain and assess-
ment of the effect of an ischemic lesion, we implanted
the human iPSC-derived lt-NESCs in the RMS, close to
the SVZ. Neurogenic areas like the SVZ support survival
and differentiation of grafted cells by molecular and cel-
lular mechanisms, which are only partially understood
[8]. We observed no significant difference in the sur-
vival, proliferation or differentiation of the grafted cells
at 2 months after transplantation in stroke-damaged as
compared to intact rat brain. In agreement, Jin and col-
laborators [16] showed that the presence of an ischemic
damage after MCAO in rats did not affect the percent-
age of mouse embryonic neural precursors implanted in
the striatum expressing phenotypic markers such as
DCX, NeuN and GFAP.
The RMS displays the most substantial, long-distance
neuronal migration in the mammalian postnatal brain. A
wide range of extracellular factors guide neuroblasts
formed in the SVZ along this migratory route, including
cell adhesion/extracellular matrix (e.g., PSA-NCAM,
integrins, and galectin-3) and axon guidance molecules
(e.g., Slit/Robo, Netrin-1/Dcc, and Erb4/Neuregulin),
growth factors (Sonic hedgehog, Nogo, and prokineticin-
2) and neurotransmitters (GABA and glutamate) [17]. It
has been reported that human fetal striatal neural stem
cells and human iPSC-derived neural precursors grafted
into the rat brain can migrate along this pathway, in
some cases a few cells reaching the MOB [8, 18]. In
contrast, we found that when the human iPSC-derived
lt-NESCs were placed in the RMS in the intact rat brain,
they only migrated a small distance from the injection
site. Hypothetically, the timing of analysis after implant-
ation could, at least partly, explain this difference in
migration of the human iPSC-derived cells between our
study (analysis at 2 months) and that of Major et al. ([8];
analysis at 3 months). Another possible explanation
for the discrepancy in migratory behavior could be
differences in the intrinsic chemotactic interaction
between the grafted neural precursor cells and their
neuronal progeny in the various transplants. Thus,
limited neuronal migration in adult brain after trans-
plantation was recently attributed to secretion of
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FGF2 and vascular endothelial growth factor (VEGF)
from grafted neural precursors, which act as chemoat-
tractants for neurons [19].
The presence of an ischemic lesion promoted the
migration of the grafted cells toward the injured area,
overcoming the regulatory signals in the intact brain.
Similar targeted migration toward the ischemic cortical
lesion has been found when human fetal neural stem
cells were transplanted into the cerebral cortex of rats
subjected to distal MCAO [20]. Also SVZ-derived
neuroblasts deviate from their migratory path and are
re-routed to sites affected by stroke-induced injury [21, 22],











































Fig. 3 Stroke alters migration pattern of human skin-derived neural progenitors transplanted adjacent to SVZ. a-d Fluorescence photomicrographs
showing migration pattern of grafted cells (GFP+, green) 2 months after transplantation in intact (a-b) and stroke-injured (c-d) rats. Low magnification
overviews (a, c) and higher magnifications of the migrating grafted cells (b, d) are presented for each condition. Note the difference in the direction
of the migratory pattern of grafted cells between the groups. e-f Analysis of mean (e) and maximum (f) distances migrated by the grafted cells from
the implantation site at 2 months after transplantation in intact (around 2000 cells analyzed per animal, n = 6) and stroke-injured (around 2000 cells
analyzed per animal, n = 7; MCAO) rats. Data represent means ± SEM; *P < 0.05, two-tailed unpaired t test. Str striatum, RMS rostral migratory stream.
Scale bars represent 500 μm in (a and c) and 100 μm in (b and d)
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migrating closely associated with blood vessels [23].
The signals regulating the migration of the grafted
human iPSC-derived lt-NESCs toward the ischemic
lesion remain to be identified. Thus, it is unclear to
what extent the same molecular and cellular mecha-
nisms support the migration of neuroblasts in the in-
tact and injured brain. Conceivably, the signals acting
on the grafted human iPSC-derived lt-NESCs closely
resemble those acting on the endogenous progenitors and
neuroblasts after stroke. Molecular mechanisms directing
these cells to the damaged area [24] include stromal cell-
derived factor-1 (SDF-1) and monocyte chemoattractant
protein-1 (MCP-1) in reactive astrocytes and activated
microglia, acting on neural progenitors and new neuro-
blasts which express the respective receptors, CXCR4 and
CCR2 [25–27]. Other molecules reported to be involved
in this neuroblast migration are ostopontin acting on
integrin ß1 receptor, matrix metalloproteinase 9 (MMP9),
erythropoietin (EPO), and platelet-derived growth factor
receptor beta (PDGFß) [28–31].
How the distance from the ischemic lesion influences
the stroke-induced migratory behavior of the grafted
cells is unclear. While some studies conclude that migra-
tion of transplanted cells toward the injury is not in-
duced at distances longer than 1 mm [32], other studies
describe long-distance (even inter-hemispheric) migra-
tion of murine stem cells implanted into the stroke-
damaged rat brain [33, 34]. In our experiments, signals
coming from the ischemic lesion were sufficient to
induce the migration of the human iPSC-derived lt-NESCs
from the RMS/SVZ in the direction of the injury, i.e., over
































































Fig. 4 Stroke alters fiber outgrowth pattern of human skin-derived neural progenitors transplanted adjacent to SVZ. a-c Fluorescence
photomicrographs showing fiber outgrowth from grafted cells (GFP+, green) 2 months after transplantation in intact and stroke-injured (MCAO) rats.
In the intact brain, grafted cells send massive numbers of fibers through the RMS (a) reaching MOB (b) including granular layer (c) and glomerular layer
(d; arrowheads depict GFP+ fibers). e-h Number of fibers crossing the rostral turn of the RMS (e and f right, and g) and reaching the MOB (e and f left,
and h), from grafted cells 2 months after transplantation in intact (n = 6) and stroke-subjected (n = 7) rats. Arrows in (e) depict massive number of
fibers in the intact brain and arrowheads in (f) depict rare fibers found in the stroke-subjected brains (MCAO). Data represent means ± SEM; *P < 0.05,
two-tailed unpaired t test. LV lateral ventricle, RMS rostral migratory stream, MOB main olfactory bulb, GrL granular layer, GL glomerular layer. Scale bars
represent 1 mm in (a), 50 μm in (b) also valid for (c and d) and 100 μm in (e and f)
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In the intact animals, we observed massive fiber out-
growth along the RMS from the grafted human iPSC-
derived lt-NESCs. A similar outgrowth was previously
shown from human tertocarcinoma cells transplanted
into the striatum of adult rat brain [7], suggesting guid-
ance cues in the adult brain that govern fiber outgrowth
(e.g., ADAM21 metalloprotease; [35]). The same signals
that regulate neuronal migration also mediate neurite
outgrowth [36]. One example is netrin proteins, which
are important regulators of axon guidance and cell
migration, and whose receptor is present on neural pre-
cursors in the adult mouse and human SVZ and RMS
[37]. Also Syndecan-3 has been reported to be crucial
for radial migration and neurite outgrowth in the devel-
oping brain [38, 39]. This transmembrane proteoglycan
is expressed in major axonal pathways and migratory
routes of the brain, including the RMS. Interestingly, our
results show that the presence of an ischemic damage in
the striatum is able to abolish the fiber outgrowth from
the grafted human iPSC-derived lt-NESCs through the
RMS observed in the intact brain. This difference in the
behavior of the grafted cells may be explained by their
migration in the direction of the ischemic lesion. The
typical unipolar morphology of the migrating neuro-
blasts is probably not compatible with sending long
fibers to distant structures like MOB, located in the
opposite direction.
Conclusions
We show here that neurons generated from transplanted
human skin-derived neural progenitors respond to sig-
nals regulating migration and fiber outgrowth in both
the intact and stroke-injured brain. The signals from the
ischemic lesion in the striatum seem to overcome those
operating in the intact brain as evidenced by stroke
causing a complete change in migratory and fiber out-
growth patterns of the graft-derived neurons. Taken to-
gether, our findings provide further evidence that
transplantation of human skin-derived neural progeni-
tors is a useful approach to supply new neurons to the
adult brain. However, the occurrence of injured tissue
strongly affects crucial parameters in the behavior of
these cells, which will be important to consider in a
potential, future clinical translation.
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